Navigation Links
Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations
Date:4/29/2010

Shah will serve as a member of the federal affairs lobbying and policy team that represents Talecris to the legislative and executive branches of government in Washington, D.C.

Research Triangle Park, NC (Vocus) April 29, 2010 -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Nimish Shah has joined the public affairs department as vice president, federal government relations.

Shah will serve as a member of the federal affairs lobbying and policy team that represents Talecris to the legislative and executive branches of government in Washington, D.C. He will collaborate with members of the public affairs team to lead Talecris’ political action committee and to educate internal and external audiences on key policy initiatives that affect Talecris’ business.

Shah brings a diverse set of skills and experience in the fields of public policy, law and business, including strategic oversight and implementation of government affairs outreach programs, regulatory and reimbursement policy development, and patient advocacy and alliance partnerships.

Before joining Talecris, Shah served as senior director and head of Takeda Pharmaceuticals’ D.C. office, where he developed and led the company’s lobbying, policy and patient advocacy functions. Prior to his position at Takeda, Shah served as director of public policy and manager of public policy and federal government affairs at Roche Pharmaceuticals. Shah spent the first twelve years of his career practicing law in Philadelphia and Washington, D.C., respectively.

Nimish earned his Bachelor of Arts degree in International Relations from Rutgers University in New Brunswick, N.J. He earned his Juris Doctor from the Rutgers School of Law and an Executive Master of Business degree from the Rutgers School of Business. He also participated in the International Law Program at Regent’s College in London, England.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

Contact:
Talecris Corporate Communications
Becky Levine, 919-316-6590

###

Read the full story at http://www.prweb.com/releases/Talecris_Biotherapeutics/Nimish_Shah/prweb3944394.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record
2. Integrative Logic Hires Sharon Maloney as Director of Business Intelligence
3. Linfield College's Adult Degree Program Hires New Associate Dean of Nursing for Distance Learning
4. Silverchair Learning Systems Enhances Product Expertise with New Hires
5. Stone Soup Technology Hires Former Scoop Magazine Publisher Melanie Feltman
6. The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession
7. Reliv International Hires Director of Strategic Development
8. Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets
9. Aegis Health Group Hires Pearson Talbert as Chief Development Officer
10. CBCA Names Tim Reed as Vice President, Human Resources
11. Statement by Irwin Redlener, MD, President, Childrens Health Fund on Passage of a Health Care Reform Package by the House
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations 
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology: